Max Robotics — Global Service Robot Directory + US Certification

About

Bertil Glader is a leading hematologist whose research has fundamentally shaped the understanding and treatment of Diamond-Blackfan anemia (DBA) and red blood cell disorders. His work bridges molecular genetics and clinical care, with a particular focus on the genetic basis of inherited anemias and the role of ribosomal proteins in disease. Glader’s most-cited study, a 2008 paper with over 400 citations, demonstrated that mutations in ribosomal proteins L5 and L11 are associated with cleft palate and abnormal thumbs in DBA patients—a landmark finding that linked specific genetic defects to congenital anomalies and refined diagnostic criteria. Beyond this, he has made critical contributions to characterizing red cell enzyme deficiencies, such as glucose-6-phosphate dehydrogenase (G6PD) deficiency, and to understanding the pathophysiology of hemolytic anemias. His work has been instrumental in establishing genotype-phenotype correlations that guide clinical management, from transfusion strategies to bone marrow transplantation. With a career spanning decades at Stanford University and Lucile Packard Children’s Hospital, Glader has also authored influential textbooks and mentored generations of hematologists. His research remains a cornerstone for clinicians and scientists investigating ribosomopathies and inherited blood disorders.